A History of IMCSzyme (and Where We Are Now)
Written by: L. Andrew Lee, Ph.D., Amanda C. McGee, Gray D. Amick, Ph.D., Caleb R. Schlachter, Ph.D. KEY TAKEAWAYS: IMCS pioneered the development of recombinant β-glucuronidases, replacing animal-derived enzymes. Continuous formulation advances (IMCSzyme®, IMCSzyme 3S, 3P, and IMCSzyme® RT) improved enzyme stability, temperature tolerance, and hydrolysis efficiency. Independent studies confirmed that IMCSzyme® β-glucuronidases provide faster, …
